Showing results (2331-2340 of 2,362) with videos related to
Sort By:
Pageof 237
Journal of Medicinal Chemistry|October 6, 2021
Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic DisordersHuji Turdi, Hannguang Chao, Jon J Hangeland, et al.The American Journal of Cardiology|February 26, 2019
Usefulness of Atherectomy in Chronic Total Occlusion Interventions (from the PROGRESS-CTO Registry)Iosif Xenogiannis, Dimitri Karmpaliotis, Khaldoon Alaswad, et al.Circulation. Cardiovascular Interventions|March 16, 2019
In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Prior Coronary Artery Bypass Graft SurgeryPeter Tajti, Dimitri Karmpaliotis, Khaldoon Alaswad, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2020
Outcomes of retrograde chronic total occlusion percutaneous coronary intervention: A report from the OPEN-CTO registrySanjog Kalra, Darshan Doshi, James Sapontis, et al.International Journal of Cardiology|July 15, 2019
Impact of concomitant treatment of non-chronic total occlusion lesions at the time of chronic total occlusion interventionIosif Xenogiannis, Dimitri Karmpaliotis, Khaldoon Alaswad, et al.Journal of Consulting and Clinical Psychology|November 15, 2019
Integrating the Hierarchical Taxonomy of Psychopathology (HiTOP) into clinical practiceCamilo J Ruggero, Roman Kotov, Christopher J Hopwood, et al.Journal of Medicinal Chemistry|September 25, 2025
Discovery of Potent and Selective Reversible Ubiquitin-Like Modifier Activating Enzyme 5 Inhibitors Targeting the UFMylation PathwayJames J Mignone, Elizabeth A Jurica, Deepa Rajasekaran, et al.Cancer Research|July 16, 2010
A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimensJing Sun, Michael D Masterman-Smith, Nicholas A Graham, et al.Journal of Medicinal Chemistry|November 3, 2015
Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311)Jennifer X Qiao, Tammy C Wang, Leonard P Adam, et al.Blood|September 13, 2012
Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plansFabio Candotti, Kit L Shaw, Linda Muul, et al.Pageof 237